Product Description
Select Opdyta (Nivolumab Injection) 100 mg/10 mL and jump on to a must-have solution against several challenging malignancies. With its grandiose formulation, this noteworthy monoclonal antibody is designed for opulent and precise cancer immunotherapy, including metastatic melanoma, non-small cell lung cancer, Hodgkin lymphoma, and more. Ready-to-use in a single-use glass vial, Opdyta is infused intravenously over 30-60 minutes under medical supervision. Preservative-free and with a shelf life of 36 months, it caters to modern clinical requirements with eminent safety, convenience, and efficacy.
Exceptional Material Feature and Purpose of Use
Opdyta Nivolumab Injection 100mg exemplifies opulent precision in cancer therapy with its preservative-free, ready-to-use formulation. Used as a monoclonal antibody for targeted immunotherapy, its special features include a colorless to pale yellow, clear solution in a single-use glass vial and pH stability between 6.0-6.5. Intended for intravenous infusion, it is suitable for various cancer types, supporting medical teams in advancing effective oncology treatment protocols.
Packaging Details, Delivery, and Supply Estimate
Each Opdyta Nivolumab Injection comes expertly packaged in a 10mL single-use glass vial for optimal preservation and sterility. The packaging ensures product integrity during transit and storage. We offer a reliable, streamlined, and secure supply process with swift delivery timelines. Estimate your procurement needs confidently-ample supply ability enables consistent availability for hospitals and clinics across India and international markets. Experience grandiose logistical support through our dependable exporter, supplier, and trader network.
FAQ's of Nivolumab Injection Opdyta 100Mg:
Q: How should Opdyta (Nivolumab Injection) be stored for optimal safety?
A: Opdyta must be stored refrigerated between 2C to 8C, protected from light, and should not be frozen to maintain its stability and effectiveness.
Q: What is the recommended administration process for Opdyta Nivolumab Injection 100mg?
A: Opdyta is administered via intravenous infusion only, typically over a duration of 30 to 60 minutes, under the supervision of trained healthcare professionals.
Q: When is Opdyta indicated for use in cancer therapy?
A: Opdyta is indicated for metastatic melanoma, non-small cell lung cancer, renal cell carcinoma, Hodgkin lymphoma, urothelial carcinoma, and other specific cancers as per clinical guidelines.
Q: What special features distinguish Opdyta from other injectable therapies?
A: Opdyta stands out as a ready-to-use, preservative-free solution in a single-use glass vial, offering a colorless to pale yellow, clear to slightly opalescent solution for reliable cancer treatment.
Q: Where can Opdyta be sourced from, and who supplies it?
A: Opdyta is available via certified exporters, suppliers, and traders in India, ensuring regulated distribution to hospitals and oncology centers both locally and internationally.
Q: What are the storage and handling precautions during delivery of Opdyta?
A: Opdyta's packaging is designed to maintain cold-chain conditions and protect from exposure to light, ensuring the product arrives in optimal condition for clinical use.